Article info

Download PDFPDF
Mental health
Methylphenidate denied access to the WHO List of Essential Medicines for the second time

Authors

  • Johanne Pereira Ribeiro Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, Denmark PubMed articlesGoogle scholar articles
  • Charlotte Lunde Centre for Medical Ethics, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Christian Gluud The Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, DenmarkDepartment of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark PubMed articlesGoogle scholar articles
  • Erik Simonsen Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, DenmarkDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Ole Jakob Storebø Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse, DenmarkDepartment of Psychology, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkDepartment of Child and Adolescent Psychiatry, Psychiatry Region Zealand, Roskilde, Denmark PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ole Jakob Storebø, Psychiatric Research Unit, Psychiatry Region Zealand, Slagelse 4200, Denmark; ojst{at}regionsjaelland.dk
View Full Text

Citation

Pereira Ribeiro J, Lunde C, Gluud C, et al
Methylphenidate denied access to the WHO List of Essential Medicines for the second time

Publication history

  • Accepted January 22, 2022
  • First published February 19, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.